Almost Family Inc (AFAM) 40.05 $AFAM Almost Family, Inc.

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 6:20 AM

Almost Family Inc (AFAM) 40.05 $AFAM

Almost Family, Inc. to Report Second Quarter 2016 Financial Results on August 3, 2016
GlobeNewswire - Mon Aug 01, 3:20PM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that it will report financial results for its second quarter 2016 on Wednesday, August 3, 2016, publishing an earnings release before the market opens.
AFAM: 40.05 (+0.26)

Almost Family, Inc. to Present at the Jefferies Healthcare Conference
GlobeNewswire - Tue Jun 07, 7:32AM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that Steve Guenthner, President and Principal Financial Officer is scheduled to present at the Jefferies Healthcare Conference in New York City.
AFAM: 40.05 (+0.26)

Almost Family Announces Home Health Entry into The State of Wisconsin
GlobeNewswire - Wed May 25, 7:30AM CDT
Almost Family, Inc. (NASDAQ:AFAM), today announced that it has entered into a transaction for entry into the State of Wisconsin through the acquisition of certain home health agency assets from ResCare Inc. Annualized revenues of $15 million, principally for personal care services, are expected to be generated across 8 branches in Wisconsin.
AFAM: 40.05 (+0.26)

DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.42 (-0.14), AFAM: 40.05 (+0.26), DVA: 77.00 (-0.54), HLS: 42.05 (-1.00)

Quest Diagnostics (DGX) Divests Focus, Cuts Sales View
Zacks Equity Research - Zacks Investment Research - Thu May 19, 5:44AM CDT
Quest Diagnostics Inc. (DGX) has updated its outlook for 2016 following the completion of the sale of Focus Diagnostics Inc.
AFAM: 40.05 (+0.26), LHCG: 45.32 (+0.06), DGX: 86.24 (-0.12), HLS: 42.05 (-1.00)

BioScrip (BIOS) Q1 Loss Wider than Expected, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:11AM CDT
BioScrip, Inc. (BIOS) reported net loss from continuing operations of 17 cents per share in the first quarter of 2016.
USPH: 58.87 (-0.75), AFAM: 40.05 (+0.26), BIOS: 2.58 (+0.02), HLS: 42.05 (-1.00)

Almost Family, Inc. to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Mon May 09, 8:14AM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that Steve Guenthner, President and Principal Financial Officer is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, Nevada.
AFAM: 40.05 (+0.26)

Amedisys (AMED) Lags Q1 Earnings, Revenues Top the Mark
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:56AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 33 cents per share in the first quarter of 2016.
BSX: 24.43 (+0.15), AFAM: 40.05 (+0.26), AMED: 55.00 (+1.45), HLS: 42.05 (-1.00)

Almost Family Reports First Quarter 2016 Results
GlobeNewswire - Wed May 04, 6:30AM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today its financial results for the quarter ended April 1, 2016.
AFAM: 40.05 (+0.26)

Almost Family, Inc. to Report First Quarter 2016 Financial Results on May 4, 2016
GlobeNewswire - Mon May 02, 6:18PM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that it will report financial results for its first quarter 2016 on Wednesday, May 4, 2016, publishing an earnings release before the market opens.
AFAM: 40.05 (+0.26)

Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 147.07 (-0.07), AFAM: 40.05 (+0.26), AMED: 55.00 (+1.45), HLS: 42.05 (-1.00)

Quest Diagnostics (DGX) Q1 Earnings in Line, Volume Up
Zacks Equity Research - Zacks Investment Research - Thu Apr 21, 8:23AM CDT
Quest Diagnostics' (DGX) first-quarter 2016 adjusted earnings per share (EPS) of $1.12 came in line with the Zacks Consensus Estimate.
BSX: 24.43 (+0.15), AFAM: 40.05 (+0.26), DGX: 86.24 (-0.12), AMED: 55.00 (+1.45)

AmSurg Poised on Strategic Buyouts, Rising Costs a Concern
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 4:46PM CDT
On Apr 18, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 72.23 (-2.78), BSX: 24.43 (+0.15), AFAM: 40.05 (+0.26), AMED: 55.00 (+1.45)

3 Reasons Value Stock Investors Will Love Almost Family (AFAM)
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 8:16AM CDT
Almost Family looks great given its impressive metrics and estimate revisions
AFAM: 40.05 (+0.26)

Amedisys Poised on Balanced Growth, Strategic Buyouts
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 1:35PM CDT
On Apr 11, 2016, we issued an updated research report on Amedisys Inc. (AMED).
AFAM: 40.05 (+0.26), CSII: 19.50 (-0.11), RMD: 69.85 (+0.97), AMED: 55.00 (+1.45)

DaVita to Acquire Mountain View, Expand Footprint in Colorado
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 1:35PM CDT
DaVita HealthCare Partners Inc. (DVA) intends to acquire Mountain View Medical Group to enhance its kidney care services and extend footprint in Colorado Springs.
ABUS: 4.17 (+0.08), AFAM: 40.05 (+0.26), DVA: 77.00 (-0.54), AMED: 55.00 (+1.45)

Strength Seen in Amedisys (AMED): Stock Soars 14.7%
Zacks Equity Research - Zacks Investment Research - Thu Mar 10, 7:00AM CST
Amedisys (AMED) was a big mover last session with its shares rising roughly 15% on the day.
AFAM: 40.05 (+0.26), AMED: 55.00 (+1.45)

3 Cheap Growth Stocks You Can Buy Right Now
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 10, 6:03AM CST
Image source: StockMonkeys.com via Flickr. When the stock market was in nearly nonstop rally mode for most of the past six years, investors didn't need to look far to uncover an abundance of growth stocks. But not all growth stocks are created...
CAL: 25.99 (-0.33), BIDU: 163.23 (+3.63), AFAM: 40.05 (+0.26)

New Strong Buy Stocks for February 9th
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
AGTC: 15.25 (+0.22), ACHC: 52.59 (-3.91), ACAS: 16.50 (+0.03), AFAM: 40.05 (+0.26), ADSK: 59.74 (+0.29)

Almost Family, Citigroup and GoPro, highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Thu Feb 04, 8:30AM CST
Almost Family, Citigroup and GoPro, highlighted as Zacks Bull and Bear of the Day
GPRO: 12.94 (+0.30), AFAM: 40.05 (+0.26), C: 43.42 (-0.39)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...